Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 52, Issue 1, 2001, Pages 57-63

  Kodama, Yasuo ^a   Kodama, Hirofumi ^a,b   Kuranari, Masae ^c   Tsutsumi, Kimiko ^c   Ono, Shunsuke ^d   Yukawa, Eiji ^e   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c OITA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Epilepsy; Gender or age effect; Protein binding characteristics; Valproic acid

Indexed keywords

ALBUMIN; FATTY ACID; PLASMA PROTEIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BINDING SITE; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; EPILEPSY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; BLOOD PROTEINS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN BINDING; SEX FACTORS; VALPROIC ACID;

EID: 0034961871     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(01)00151-5     Document Type: Article

References (28)

1. Drug treatment of epilepsy
2. The new generation of antiepileptic drugs: advantages and disadvantages
3. Clinical pharmacokinetics of valproic acid - 1988
4. Non-linear pharmacokinetics: clinical implications
5. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing
6. In vivo determination of valproate binding constants during sole and multi-drug therapy
7. Decreased plasma protein binding of valproate in patients with acute head trauma
8. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy
9. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination
10. Determination of free valproic acid concentrations using the amicon micropartition MPS-1 ultrafiltration system
11. pH lability in serum during equilibrium dialysis
12. Binding parameters of valproic acid to serum protein in healthy adults at steady state
13. Effect of unbound clearance on binding parameters of valproic acid to serum proteins
14. Problems in therapeutic drug monitoring: free drug level monitoring
15. SI units in drug therapeutics
16. Valproic acid: in vitro plasma protein binding and interaction with phenytoin
17. Diurnal oscillations in plasma protein binding of valproic acid
18. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults
19. Formation of active metabolites of anticonvulsant drugs: a review of their pharmacokinetic and therapeutic significance
20. Urinary excretion of valproate and some metabolites in chronically treated patients
21. Serum albumin: recent progress in the understanding of its structure and biosynthesis
22. Characterization of a small apolar anion binding site of human serum albumin
23. Location of the medium chain fatty acid site on human serum albumin
24. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites
25. Plasma and tissue protein binding of drugs in pharmacokinetics
26. Diseases and drug protein binding
27. Age-related changes in protein binding of drugs: implications for therapy